glp 1 receptor antagonist drugs GLP-1 Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care Evolution of GLP‐1 Receptor Agonists
Description
When the pharmacological appetite suppression is reduced or withdrawn, the caloric threshold required to maintain their new weight is lower than expected, but their appetite, shaped by the neurological reward pathways that GLP-1s modulate, does not stay suppressed indefinitely without ongoing treatment
J Ovarian Res 2025
Greenfield NJ
Side effects were more common in the oral semaglutide group (16.7%) than in the injection group (4.9%)
